CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy

Hyung-seung Jin; Minkyung Ko; Da-som Choi; June Hyuck Kim; Dong-hee Lee; Seong-Ho Kang; Inki Kim; Hee Jin Lee; Eun Kyung Choi; Kyu-pyo Kim; Changhoon Yoo; Yoon Park

doi:10.1158/2326-6066.CIR-19-0877

Research Articles

CD226^hiCD8⁺ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy

Hyung-seung Jin, Minkyung Ko, Da-som Choi, June Hyuck Kim, Dong-hee Lee, Seong-Ho Kang, Inki Kim, Hee Jin Lee, Eun Kyung Choi, Kyu-pyo Kim, Changhoon Yoo and Yoon Park

Hyung-seung Jin

1Department of Convergence Medicine, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Hyung-seung Jin
For correspondence: hsjin@amc.seoul.kr cyoo.amc@gmail.com ypark@kist.re.kr

Minkyung Ko

2Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul, South Korea.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Minkyung Ko

Da-som Choi

1Department of Convergence Medicine, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

June Hyuck Kim

1Department of Convergence Medicine, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Dong-hee Lee

1Department of Convergence Medicine, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Seong-Ho Kang

2Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul, South Korea.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Seong-Ho Kang

Inki Kim

1Department of Convergence Medicine, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hee Jin Lee

3Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Eun Kyung Choi

4Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kyu-pyo Kim

5Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Changhoon Yoo

5Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: hsjin@amc.seoul.kr cyoo.amc@gmail.com ypark@kist.re.kr

Yoon Park

2Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul, South Korea.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: hsjin@amc.seoul.kr cyoo.amc@gmail.com ypark@kist.re.kr

DOI: 10.1158/2326-6066.CIR-19-0877 Published July 2020

Article
Figures & Data
Info & Metrics
PDF

This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.

Log in using your username and password

Username *

Password *

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

PreviousNext

July 2020
Volume 8, Issue 7

Table of Contents
Table of Contents (PDF)
About the Cover
Editorial Board (PDF)

Search for this keyword

View this article with LENS

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Cancer Immunology Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy

Message Subject (Your Name) has forwarded a page to you from Cancer Immunology Research

Message Body (Your Name) thought you would be interested in this article in Cancer Immunology Research.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

CD226^hiCD8⁺ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy

Hyung-seung Jin, Minkyung Ko, Da-som Choi, June Hyuck Kim, Dong-hee Lee, Seong-Ho Kang, Inki Kim, Hee Jin Lee, Eun Kyung Choi, Kyu-pyo Kim, Changhoon Yoo and Yoon Park

Cancer Immunol Res July 1 2020 (8) (7) 912-925; DOI: 10.1158/2326-6066.CIR-19-0877

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

CD226^hiCD8⁺ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy

Hyung-seung Jin, Minkyung Ko, Da-som Choi, June Hyuck Kim, Dong-hee Lee, Seong-Ho Kang, Inki Kim, Hee Jin Lee, Eun Kyung Choi, Kyu-pyo Kim, Changhoon Yoo and Yoon Park

Cancer Immunol Res July 1 2020 (8) (7) 912-925; DOI: 10.1158/2326-6066.CIR-19-0877

Share This Article: